patents

PHILADELPHIA--(BUSINESS WIRE)-- #biologics--VintaBio™, a technology-forward company, announced today that it has filed provisional patents with the US Patent Office describing its novel approach to manufacturing biotherapeutics using adherent culturing methods in a small-scale process. Improving upon the adherent manufacturing approaches used for FDA-approved gene therapies, such as Zolgensma™ and Luxturna™, VintaBio has designed a purpose-built process that reduces large operational footprints that restric

(NYSE:NWN) BOSTON--(BUSINESS WIRE)--NWN, the leading AI-powered technology solutions provider, today announced that the United States Patent and Trademark Office (USPTO) will be issuing a patent providing the company with broad coverage for the core intelligence underpinning its proprietary Experience Management Platform (EMP). The newly issued patent, titled, “System and Method for Unified Communication Monitoring,” validates and protects NWN’s unique approach to collecting, correlating and analyzing rea

(NASDAQ:NAOV) TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that the United States Patent and Trademark Office issued U.S. Patent No. 12,409,105 B2, titled “Insertion Device Positioning Guidance System and Method” on September 9, 2025 to ENvue Medical Holdings LLC (formerly ENvue Medical Holdings, Corp.), a wholly-owned subsidiary of the Company (“ENvue” or “ENv

Patent Publication (WO 2025 168944 A1) and subsequent PCT filing solidifies R&D leadership in Advanced Neurotherapeutics for Alzheimer's, Parkinson's and Related Disorders CHARLOTTESVILLE, Va., Sept. 11, 2025 /PRNewswire/ -- Gene Solutions, a leader in mitochondrial dysfunction genomics...

CLEVELAND--(BUSINESS WIRE)-- #ai--Sports Data Labs, Inc. (“SDL”), an award-winning leader in AI-based collection, analysis, and distribution of human data from sensors and other systems, announced today that the Patent Office, Government of India has issued Patent No. 570364 to the company covering a novel data request and distribution system for sensor-based human data (e.g., tracking data, physiological data, biomechanical data, biological fluid data, genetic data, genomic data, other electronic me

(NASDAQ:SHLS) Shoals Technologies Group Secures a New Patent for BLA Architecture, Reinforcing American Intellectual Property

(DMTR) DiagMetrics, Inc. has been granted three U.S. patents — 12,369,816; 12,092,639; and 12,031,982 — covering its Mask-Based Diagnostic™ (MBD™) platform for collecting and analyzing exhaled breath condensate (EBC). These patents secure broad protection for the company's innovations in EBC...

NICOSIA, Cyprus, Sept. 4, 2025 /PRNewswire/ -- ISX Financial EU plc is pleased to announce that its wholly owned subsidiary, ISX IP Ltd, has been advised of European Patent Office's decision to grant to ISX IP Ltd a further European Patent 3850508 – Remotely Verifying An Identity of a...

NICOSIA, Cyprus, Sept. 4, 2025 /PRNewswire/ -- ISX Financial EU plc is pleased to announce that its wholly owned subsidiary, ISX IP Ltd, has been advised of European Patent Office's decision to grant to ISX IP Ltd a further European Patent 3850508 – Remotely Verifying An Identity of a...

Company now holds six issued patents across three countries, reinforcing Ultrasound AI's position as a leader in AI-powered medical imaging Groundbreaking patent on predicting quantitative clinical and laboratory values directly from medical images DENVER, Sept. 4, 2025 /PRNewswire/ --...

(NASDAQ:NAOV) TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that the United States Patent and Trademark Office issued U.S. Patent No. 12,402,953 B2, titled “Insertion Device Positioning Guidance System and Method” on September 2, 2025 to ENvue Medical Holdings LLC (formerly ENvue Medical Holdings, Corp.), a wholly-owned subsidiary of the Company (“ENvue” or “ENv

Patent grant broadens IP protection in Asia and complements prior patents in Europe, the United States and India Hong Kong represents a meaningful diabetes market and a critical gateway into Mainland China—including the Greater Bay Area—supporting future clinical collaboration, partnering...

Strengthens Company’s Intellectual Property and Reinforces Leadership in Advanced Power Systems Strengthens Company’s Intellectual Property and Reinforces Leadership in Advanced Power Systems

Wishpond files three new patent applications for conversational AI workflow building, adaptive voicemail/IVR detection, and real-time appointment scheduling, expanding its portfolio of innovations in conversational AI and sales automation. These filings bring Wishpond's total patent...

HENDERSON, Nev.--(BUSINESS WIRE)-- #CHF--Corstasis Therapeutics Inc. (www.corstasis.com), a late clinical-stage innovator of outpatient therapies for the treatment of fluid overload in patients with cardiorenal and hepatic diseases, announced today that the U.S. Patent and Trade Office (USPTO) has allowed a new patent for its proprietary subcutaneous bumetanide formulations expanding its pipeline beyond Enbumyst™ (bumetanide nasal spray) into subcutaneous dose forms. The mission of Corstasis Therapeut

(RDGL) Kennewick, WA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc filed a provisional patent No.: 63/873,014 - STERILE THERMOGELS

(NASDAQ:SILO) SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent Office) has granted patent number 2020271839 to Silo’s research and licensing partner Columbia University for the invention titled “Prophylactic efficacy of serotonin 4 receptor agonists against stress” exclusively licensed to Silo by Columbia University.

(NASDAQ:ESGL) ESGL announces patent filing for innovation that transforms toxic HF waste into useful fluorspar, reinforcing carbon-neutral, circular operations.

Estate planning meets blockchain HYANNIS, Mass., Sept. 2, 2025 /PRNewswire-PRWeb/ -- WealthChain Protocols, LLC announced the filing of a pioneering patent for its WEALTH Blockchain™, an innovative platform that aims to revolutionize estate planning and asset protection through...

MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- AccuKnox, a leader in Zero Trust Kubernetes and cloud-native security solutions, has been issued a patent [US Patent# 12,242,629 - full PDF copy available] by the U.S. Patent and Trademark Office for the breakthrough technology in Runtime...